Leflunomide Therapy for Polyomavirus-Induced Allograft Nephropathy: Efficient BK Virus Elimination Without Increased Risk of Rejection
Authors:
- S. TeschnerSTS. Teschner
- P. GerkePGP. Gerke
- M. GeyerMGM. Geyer
- J. WilpertJWJ. Wilpert
- B. KrummeBKB. Krumme
- T. BenzingTBT. Benzing
- G. WalzGWG. Walz
- 1 July 2009
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 41 (6) , 2533-2538
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantationTransplant International, 2007
- Remission of polyomavirus-induced graft nephropathy treated with low-dose leflunomideNephrology Dialysis Transplantation, 2006
- Treatment of Renal Allograft Polyoma BK Virus Infection with LeflunomideTransplantation, 2006
- Leflunomide for Polyomavirus Type BK NephropathyNew England Journal of Medicine, 2005
- Effect of Leflunomide and Cidofovir on Replication of BK Virus in an In Vitro Culture SystemTransplantation, 2005
- Seroepidemiology of the human polyomavirusesJournal of General Virology, 2003
- Prospective Study of Polyomavirus Type BK Replication and Nephropathy in Renal-Transplant RecipientsNew England Journal of Medicine, 2002
- Clinical Course of Polyoma Virus Nephropathy in 67 Renal Transplant PatientsJournal of the American Society of Nephrology, 2002
- NOVEL MECHANISM OF INHIBITION OF CYTOMEGALOVIRUS BY THE EXPERIMENTAL IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE1,2Transplantation, 1999
- Inhibition of Cytomegalovirus in vitro and in vivo by the Experimental Immunosuppressive Agent LeflunomideIntervirology, 1999